| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process | 5.61e-06 | 13 | 57 | 3 | GO:2001054 | |
| GeneOntologyBiologicalProcess | positive regulation of metanephric DCT cell differentiation | 7.50e-06 | 2 | 57 | 2 | GO:2000594 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in metanephric collecting duct development | 7.50e-06 | 2 | 57 | 2 | GO:1900214 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in metanephric collecting duct development | 7.50e-06 | 2 | 57 | 2 | GO:1900215 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in metanephric nephron tubule development | 7.50e-06 | 2 | 57 | 2 | GO:1900218 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in metanephric nephron tubule development | 7.50e-06 | 2 | 57 | 2 | GO:1900217 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 7.50e-06 | 2 | 57 | 2 | GO:1901147 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in metanephric nephron tubule development | 7.50e-06 | 2 | 57 | 2 | GO:1900205 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in metanephric collecting duct development | 7.50e-06 | 2 | 57 | 2 | GO:1900204 | |
| GeneOntologyBiologicalProcess | regulation of metanephric DCT cell differentiation | 7.50e-06 | 2 | 57 | 2 | GO:2000592 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 7.50e-06 | 2 | 57 | 2 | GO:0072305 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 7.50e-06 | 2 | 57 | 2 | GO:0072304 | |
| GeneOntologyBiologicalProcess | kidney field specification | 7.50e-06 | 2 | 57 | 2 | GO:0072004 | |
| GeneOntologyBiologicalProcess | pronephric field specification | 7.50e-06 | 2 | 57 | 2 | GO:0039003 | |
| GeneOntologyBiologicalProcess | pattern specification involved in pronephros development | 7.50e-06 | 2 | 57 | 2 | GO:0039017 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process | 1.32e-05 | 17 | 57 | 3 | GO:2001053 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process | 1.88e-05 | 19 | 57 | 3 | GO:0097152 | |
| GeneOntologyBiologicalProcess | metanephric DCT cell differentiation | 2.25e-05 | 3 | 57 | 2 | GO:0072240 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis | 2.25e-05 | 3 | 57 | 2 | GO:0072309 | |
| GeneOntologyBiologicalProcess | kidney rudiment formation | 2.25e-05 | 3 | 57 | 2 | GO:0072003 | |
| GeneOntologyBiologicalProcess | DCT cell differentiation | 2.25e-05 | 3 | 57 | 2 | GO:0072069 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 4.49e-05 | 4 | 57 | 2 | GO:0072108 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in metanephros development | 4.49e-05 | 4 | 57 | 2 | GO:1900212 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in metanephros development | 4.49e-05 | 4 | 57 | 2 | GO:1900211 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in nephron morphogenesis | 4.49e-05 | 4 | 57 | 2 | GO:1901145 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule formation | 4.49e-05 | 4 | 57 | 2 | GO:0072289 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in metanephros development | 4.49e-05 | 4 | 57 | 2 | GO:1900200 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | 4.49e-05 | 4 | 57 | 2 | GO:0072040 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | 4.49e-05 | 4 | 57 | 2 | GO:0072039 | |
| GeneOntologyBiologicalProcess | urogenital system development | 6.75e-05 | 79 | 57 | 4 | GO:0001655 | |
| GeneOntologyBiologicalProcess | metanephric distal convoluted tubule development | 7.46e-05 | 5 | 57 | 2 | GO:0072221 | |
| GeneOntologyBiologicalProcess | metanephric distal tubule development | 7.46e-05 | 5 | 57 | 2 | GO:0072235 | |
| GeneOntologyBiologicalProcess | negative regulation of somatic stem cell population maintenance | 7.46e-05 | 5 | 57 | 2 | GO:1904673 | |
| GeneOntologyBiologicalProcess | distal convoluted tubule development | 7.46e-05 | 5 | 57 | 2 | GO:0072025 | |
| GeneOntologyBiologicalProcess | metanephric tubule formation | 1.12e-04 | 6 | 57 | 2 | GO:0072174 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell differentiation involved in kidney development | 1.56e-04 | 7 | 57 | 2 | GO:2000698 | |
| GeneOntologyBiologicalProcess | metanephric collecting duct development | 1.56e-04 | 7 | 57 | 2 | GO:0072205 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule epithelial cell differentiation | 1.56e-04 | 7 | 57 | 2 | GO:0072257 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule morphogenesis | 1.56e-04 | 7 | 57 | 2 | GO:0072282 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in morphogenesis | 1.56e-04 | 7 | 57 | 2 | GO:1902338 | |
| GeneOntologyBiologicalProcess | regulation of metanephric nephron tubule epithelial cell differentiation | 1.56e-04 | 7 | 57 | 2 | GO:0072307 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in nephron morphogenesis | 1.56e-04 | 7 | 57 | 2 | GO:0072038 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in development | 2.08e-04 | 8 | 57 | 2 | GO:1904746 | |
| GeneOntologyBiologicalProcess | pattern specification involved in kidney development | 2.08e-04 | 8 | 57 | 2 | GO:0061004 | |
| GeneOntologyBiologicalProcess | renal system pattern specification | 2.08e-04 | 8 | 57 | 2 | GO:0072048 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.67e-04 | 9 | 57 | 2 | GO:0003339 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 2.98e-04 | 47 | 57 | 3 | GO:1902742 | |
| GeneOntologyBiologicalProcess | metanephric tubule morphogenesis | 3.33e-04 | 10 | 57 | 2 | GO:0072173 | |
| GeneOntologyBiologicalProcess | distal tubule development | 3.33e-04 | 10 | 57 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | pronephros development | 3.33e-04 | 10 | 57 | 2 | GO:0048793 | |
| GeneOntologyBiologicalProcess | dopaminergic neuron differentiation | 3.58e-04 | 50 | 57 | 3 | GO:0071542 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 4.85e-04 | 236 | 57 | 5 | GO:0061138 | |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition involved in metanephros morphogenesis | 4.86e-04 | 12 | 57 | 2 | GO:0003337 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 4.86e-04 | 12 | 57 | 2 | GO:0038063 | |
| GeneOntologyBiologicalProcess | regulation of nephron tubule epithelial cell differentiation | 5.74e-04 | 13 | 57 | 2 | GO:0072182 | |
| GeneOntologyBiologicalProcess | regulation of somatic stem cell population maintenance | 5.74e-04 | 13 | 57 | 2 | GO:1904672 | |
| GeneOntologyBiologicalProcess | collecting duct development | 5.74e-04 | 13 | 57 | 2 | GO:0072044 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 7.26e-04 | 258 | 57 | 5 | GO:0001763 | |
| GeneOntologyBiologicalProcess | nephron tubule epithelial cell differentiation | 7.70e-04 | 15 | 57 | 2 | GO:0072160 | |
| GeneOntologyBiologicalProcess | metanephric renal vesicle morphogenesis | 7.70e-04 | 15 | 57 | 2 | GO:0072283 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in morphogenesis | 7.70e-04 | 15 | 57 | 2 | GO:1902337 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription | 8.78e-04 | 16 | 57 | 2 | GO:0006369 | |
| GeneOntologyBiologicalProcess | branching involved in ureteric bud morphogenesis | 8.83e-04 | 68 | 57 | 3 | GO:0001658 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in development | 9.94e-04 | 17 | 57 | 2 | GO:1904748 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 1.12e-03 | 18 | 57 | 2 | GO:0038065 | |
| GeneOntologyBiologicalProcess | renal vesicle morphogenesis | 1.12e-03 | 18 | 57 | 2 | GO:0072077 | |
| GeneOntologyBiologicalProcess | ureteric bud morphogenesis | 1.13e-03 | 74 | 57 | 3 | GO:0060675 | |
| GeneOntologyBiologicalProcess | ear development | 1.13e-03 | 285 | 57 | 5 | GO:0043583 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation involved in kidney development | 1.24e-03 | 19 | 57 | 2 | GO:2000696 | |
| GeneOntologyBiologicalProcess | renal vesicle development | 1.24e-03 | 19 | 57 | 2 | GO:0072087 | |
| GeneOntologyBiologicalProcess | mesonephric tubule morphogenesis | 1.31e-03 | 78 | 57 | 3 | GO:0072171 | |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition | 1.38e-03 | 20 | 57 | 2 | GO:0060231 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule development | 1.52e-03 | 21 | 57 | 2 | GO:0072234 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in metanephros development | 1.67e-03 | 22 | 57 | 2 | GO:0072202 | |
| GeneOntologyBiologicalProcess | positive regulation of branching involved in ureteric bud morphogenesis | 1.67e-03 | 22 | 57 | 2 | GO:0090190 | |
| GeneOntologyBiologicalProcess | nephron tubule morphogenesis | 1.80e-03 | 87 | 57 | 3 | GO:0072078 | |
| GeneOntologyBiologicalProcess | metanephric nephron epithelium development | 1.83e-03 | 23 | 57 | 2 | GO:0072243 | |
| GeneOntologyBiologicalProcess | metanephric nephron morphogenesis | 1.83e-03 | 23 | 57 | 2 | GO:0072273 | |
| GeneOntologyBiologicalProcess | nephron tubule formation | 1.83e-03 | 23 | 57 | 2 | GO:0072079 | |
| GeneOntologyBiologicalProcess | nephron epithelium morphogenesis | 1.92e-03 | 89 | 57 | 3 | GO:0072088 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in ureteric bud morphogenesis | 1.99e-03 | 24 | 57 | 2 | GO:0090189 | |
| GeneOntologyBiologicalProcess | nephron morphogenesis | 2.05e-03 | 91 | 57 | 3 | GO:0072028 | |
| GeneOntologyBiologicalProcess | renal tubule morphogenesis | 2.18e-03 | 93 | 57 | 3 | GO:0061333 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 2.19e-03 | 198 | 57 | 4 | GO:0048754 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.29e-03 | 1269 | 57 | 10 | GO:0009887 | |
| GeneOntologyBiologicalProcess | metanephric tubule development | 2.34e-03 | 26 | 57 | 2 | GO:0072170 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell population maintenance | 2.34e-03 | 26 | 57 | 2 | GO:1902455 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 2.71e-03 | 28 | 57 | 2 | GO:0106030 | |
| GeneOntologyBiologicalProcess | metanephric epithelium development | 2.71e-03 | 28 | 57 | 2 | GO:0072207 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 2.71e-03 | 28 | 57 | 2 | GO:0007413 | |
| GeneOntologyBiologicalProcess | metanephros morphogenesis | 2.90e-03 | 29 | 57 | 2 | GO:0003338 | |
| GeneOntologyCellularComponent | proteasome regulatory particle, lid subcomplex | 2.24e-04 | 8 | 60 | 2 | GO:0008541 | |
| HumanPheno | Potter facies | 1.68e-05 | 13 | 21 | 3 | HP:0002009 | |
| HumanPheno | Facial shape deformation | 3.96e-05 | 17 | 21 | 3 | HP:0011334 | |
| HumanPheno | Beta 2-microglobulinuria | 9.67e-05 | 4 | 21 | 2 | HP:0025466 | |
| MousePheno | absent uterine horn | 1.01e-05 | 2 | 45 | 2 | MP:0009215 | |
| MousePheno | absent efferent ductules of testis | 3.03e-05 | 3 | 45 | 2 | MP:0004729 | |
| Domain | Pax2_C | 3.15e-08 | 3 | 60 | 3 | IPR022130 | |
| Domain | Pax2_C | 3.15e-08 | 3 | 60 | 3 | PF12403 | |
| Domain | PAX | 2.61e-06 | 9 | 60 | 3 | SM00351 | |
| Domain | Paired_dom | 2.61e-06 | 9 | 60 | 3 | IPR001523 | |
| Domain | PAIRED_2 | 2.61e-06 | 9 | 60 | 3 | PS51057 | |
| Domain | PAX | 2.61e-06 | 9 | 60 | 3 | PF00292 | |
| Domain | PAIRED_1 | 2.61e-06 | 9 | 60 | 3 | PS00034 | |
| Domain | Fumarylacetoacetase_C-rel | 6.06e-05 | 4 | 60 | 2 | IPR011234 | |
| Domain | FAA_hydrolase | 6.06e-05 | 4 | 60 | 2 | PF01557 | |
| Domain | - | 6.06e-05 | 4 | 60 | 2 | 3.90.850.10 | |
| Domain | Homeodomain-like | 4.23e-03 | 332 | 60 | 5 | IPR009057 | |
| Pathway | WP_ID_SIGNALING | 1.54e-05 | 16 | 44 | 3 | M39359 | |
| Pubmed | PAX immunoreactivity in poorly differentiated small round cell tumors of childhood. | 5.13e-09 | 3 | 61 | 3 | 24897005 | |
| Pubmed | Pax-5 is expressed at the midbrain-hindbrain boundary during mouse development. | 5.13e-09 | 3 | 61 | 3 | 1283313 | |
| Pubmed | Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. | 2.05e-08 | 4 | 61 | 3 | 11134340 | |
| Pubmed | Two Pax-binding sites are required for early embryonic brain expression of an Engrailed-2 transgene. | 2.05e-08 | 4 | 61 | 3 | 8625814 | |
| Pubmed | Roles of Pax-genes in developing and adult brain as suggested by expression patterns. | 1.02e-07 | 6 | 61 | 3 | 8126546 | |
| Pubmed | Mapping of the human homologs of the murine paired-box-containing genes. | 1.02e-07 | 6 | 61 | 3 | 8431641 | |
| Pubmed | Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8. | 2.86e-07 | 8 | 61 | 3 | 11704761 | |
| Pubmed | 4.28e-07 | 9 | 61 | 3 | 7883790 | ||
| Pubmed | 4.28e-07 | 9 | 61 | 3 | 10197584 | ||
| Pubmed | Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. | 4.28e-07 | 9 | 61 | 3 | 7981748 | |
| Pubmed | Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero. | 8.39e-07 | 11 | 61 | 3 | 35645295 | |
| Pubmed | 1.45e-06 | 13 | 61 | 3 | 17166926 | ||
| Pubmed | Pax: a murine multigene family of paired box-containing genes. | 2.30e-06 | 15 | 61 | 3 | 1685142 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21836481 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23328975 | ||
| Pubmed | Differential expression of murine CGI-105 gene in 3T3-L1 cells by adrenocorticotropic hormones. | 3.03e-06 | 2 | 61 | 2 | 15774318 | |
| Pubmed | PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis. | 3.03e-06 | 2 | 61 | 2 | 35387670 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 8413205 | ||
| Pubmed | PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. | 3.03e-06 | 2 | 61 | 2 | 23194047 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 37977366 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22807381 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10662641 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21989345 | ||
| Pubmed | Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. | 3.03e-06 | 2 | 61 | 2 | 1723950 | |
| Pubmed | A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall. | 3.03e-06 | 2 | 61 | 2 | 26404914 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24334997 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 35926290 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21934480 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25500505 | ||
| Pubmed | Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor. | 3.03e-06 | 2 | 61 | 2 | 16814811 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 1337742 | ||
| Pubmed | PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas. | 3.03e-06 | 2 | 61 | 2 | 23163626 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26823795 | ||
| Pubmed | PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia. | 3.03e-06 | 2 | 61 | 2 | 23202787 | |
| Pubmed | PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors. | 3.03e-06 | 2 | 61 | 2 | 24992169 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP2 CELSR3 LRRC24 MTG2 NAGLU PAX2 HERC1 MED13L MBD6 SIPA1L2 HOXB13 | 3.09e-06 | 1105 | 61 | 11 | 35748872 |
| Pubmed | 4.88e-06 | 19 | 61 | 3 | 8575294 | ||
| Pubmed | 5.73e-06 | 20 | 61 | 3 | 26658320 | ||
| Pubmed | Sall1 balances self-renewal and differentiation of renal progenitor cells. | 6.04e-06 | 67 | 61 | 4 | 24550112 | |
| Pubmed | Hes1 and Hes3 regulate maintenance of the isthmic organizer and development of the mid/hindbrain. | 6.68e-06 | 21 | 61 | 3 | 11500373 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 22495365 | ||
| Pubmed | A universal metabolite repair enzyme removes a strong inhibitor of the TCA cycle. | 9.07e-06 | 3 | 61 | 2 | 38287013 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 1516825 | ||
| Pubmed | Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage. | 9.07e-06 | 3 | 61 | 2 | 17047028 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 32381599 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 7856737 | ||
| Pubmed | Diagnostic Utility of Pax8, Pax2, and NGFR Immunohistochemical Expression in Pediatric Renal Tumors. | 9.07e-06 | 3 | 61 | 2 | 28426529 | |
| Pubmed | Pax2.1 is required for the development of thyroid follicles in zebrafish. | 9.07e-06 | 3 | 61 | 2 | 12117823 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21263247 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 26797858 | ||
| Pubmed | Characterization of a novel Lbx1 mouse loss of function strain. | 1.30e-05 | 26 | 61 | 3 | 34906895 | |
| Pubmed | 1.30e-05 | 26 | 61 | 3 | 21303848 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 1.46e-05 | 27 | 61 | 3 | 18649358 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 23196794 | ||
| Pubmed | Functional equivalence of the transcription factors Pax2 and Pax5 in mouse development. | 1.81e-05 | 4 | 61 | 2 | 10934015 | |
| Pubmed | Pax2/Pax8-defined subdomains and the occurrence of apoptosis in the posterior placodal area of mice. | 1.81e-05 | 4 | 61 | 2 | 28160066 | |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 7577673 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 23503645 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 8099544 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 1485966 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 22308434 | ||
| Pubmed | Development of a screening set for new (CAG/CTG)n dynamic mutations. | 4.52e-05 | 6 | 61 | 2 | 8786123 | |
| Pubmed | Pbx1 is essential for adrenal development and urogenital differentiation. | 4.52e-05 | 6 | 61 | 2 | 14595835 | |
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 25279712 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 12435636 | ||
| Pubmed | Pax2 contributes to inner ear patterning and optic nerve trajectory. | 6.32e-05 | 7 | 61 | 2 | 8951055 | |
| Pubmed | FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. | 6.32e-05 | 7 | 61 | 2 | 22698282 | |
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 9405645 | ||
| Pubmed | Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. | 6.32e-05 | 7 | 61 | 2 | 7990960 | |
| Pubmed | A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. | 6.32e-05 | 7 | 61 | 2 | 7590254 | |
| Pubmed | Pbx1 regulates nephrogenesis and ureteric branching in the developing kidney. | 6.32e-05 | 7 | 61 | 2 | 12591246 | |
| Pubmed | Cooperation of Pax2 and Pax5 in midbrain and cerebellum development. | 6.32e-05 | 7 | 61 | 2 | 9159136 | |
| Pubmed | 7.43e-05 | 1285 | 61 | 10 | 35914814 | ||
| Pubmed | 7.98e-05 | 407 | 61 | 6 | 12693553 | ||
| Pubmed | Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. | 8.42e-05 | 8 | 61 | 2 | 10471511 | |
| Pubmed | AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. | 8.42e-05 | 8 | 61 | 2 | 9343407 | |
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 22474389 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 8.42e-05 | 8 | 61 | 2 | 10970885 | |
| Pubmed | 9.10e-05 | 606 | 61 | 7 | 36538041 | ||
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 15520281 | ||
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 29377931 | ||
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 15872005 | ||
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 12874121 | ||
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 15741321 | ||
| Pubmed | Characterization of lipid-linked oligosaccharide accumulation in mouse models of Batten disease. | 1.08e-04 | 9 | 61 | 2 | 15647513 | |
| Pubmed | Pax2 and Pax8 cooperate in mouse inner ear morphogenesis and innervation. | 1.08e-04 | 9 | 61 | 2 | 20727173 | |
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 18522499 | ||
| Pubmed | 1.32e-04 | 446 | 61 | 6 | 24255178 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 15872002 | ||
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 22167068 | ||
| Pubmed | The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. | 1.65e-04 | 11 | 61 | 2 | 16243425 | |
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 16916509 | ||
| Pubmed | Pax2/5 and Pax6 subdivide the early neural tube into three domains. | 1.65e-04 | 11 | 61 | 2 | 10354469 | |
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 23920117 | ||
| Pubmed | Homeobox genes: a link between development, cell cycle, and cancer? | 1.65e-04 | 11 | 61 | 2 | 10328847 | |
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 17300925 | ||
| Pubmed | β-Catenin in the kidney stroma modulates pathways and genes to regulate kidney development. | 1.65e-04 | 11 | 61 | 2 | 37227110 | |
| Pubmed | Fgf3 and Fgf10 are required for mouse otic placode induction. | 1.65e-04 | 11 | 61 | 2 | 12810586 | |
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 16530751 | ||
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 16501559 | ||
| GeneFamily | Paired boxes | 7.13e-07 | 9 | 38 | 3 | 675 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 9.45e-04 | 92 | 38 | 3 | 521 | |
| Coexpression | GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN | 6.77e-06 | 198 | 61 | 6 | M7480 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP | 6.97e-06 | 199 | 61 | 6 | M7474 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.21e-06 | 183 | 61 | 5 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.35e-06 | 184 | 61 | 5 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.79e-06 | 187 | 61 | 5 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-06 | 190 | 61 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-06 | 190 | 61 | 5 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-06 | 193 | 61 | 5 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.28e-06 | 196 | 61 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.28e-06 | 196 | 61 | 5 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 7.28e-06 | 196 | 61 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | severe_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 4.44e-05 | 143 | 61 | 4 | 28b0e168126a9fe60541dc12bfab385b7a0a2342 | |
| ToppCell | severe_COVID-19-B_cell|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.56e-05 | 144 | 61 | 4 | c7f696e55e2d959c58ec32640c71ef86ee25203c | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.68e-05 | 145 | 61 | 4 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 5.63e-05 | 152 | 61 | 4 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.07e-05 | 155 | 61 | 4 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-05 | 159 | 61 | 4 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-05 | 162 | 61 | 4 | b877b232f0a879a9058d81ad4730e7846484b7c3 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-05 | 162 | 61 | 4 | 7384a4dd38ed68ca02a72df6deff4d34c9694ce1 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.73e-05 | 165 | 61 | 4 | ec16a4979b3f203c9f66ed387a7a17bf3a1d3f86 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.48e-05 | 169 | 61 | 4 | e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.48e-05 | 169 | 61 | 4 | d375a1df1ecc938f66bad92e54b8cda26ca9c472 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.48e-05 | 169 | 61 | 4 | 58f805c0be507bd5fadc9ea3555032daabbc8ab8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.88e-05 | 171 | 61 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.88e-05 | 171 | 61 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-05 | 172 | 61 | 4 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-05 | 172 | 61 | 4 | 6004327045f03d832fdabe6cb2f8b1b1db57789a | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-05 | 172 | 61 | 4 | 31c5710fd7ebb221e703545595f5ec0ee3a32bcf | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-05 | 172 | 61 | 4 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 9.50e-05 | 174 | 61 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-05 | 176 | 61 | 4 | dc5a22f9d1347f157bdd93e6e5769b983deccf1a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.08e-04 | 180 | 61 | 4 | c3d1521ac90f2e3fc31158e6e61907e05c37af39 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-04 | 181 | 61 | 4 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 181 | 61 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 182 | 61 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 184 | 61 | 4 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 185 | 61 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 185 | 61 | 4 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-04 | 186 | 61 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Lymphoid-Tregs|Control / Condition, Lineage and Cell class | 1.23e-04 | 186 | 61 | 4 | 6144f32a370594e45b91da142b4f435370c69b9a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 186 | 61 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-04 | 187 | 61 | 4 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 187 | 61 | 4 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.28e-04 | 188 | 61 | 4 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.28e-04 | 188 | 61 | 4 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 188 | 61 | 4 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 61 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-04 | 191 | 61 | 4 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 192 | 61 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 0e39b6c8e7382e61a9891f6c7e3df2a859788219 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 74 | 61 | 3 | 216721986c3055f2d9b4702be9693b3a0892283c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 74 | 61 | 3 | a7f7ed7316c226e18ee62d0149be7404326817c6 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.44e-04 | 194 | 61 | 4 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-04 | 194 | 61 | 4 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.47e-04 | 195 | 61 | 4 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.47e-04 | 195 | 61 | 4 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 196 | 61 | 4 | d323f7dc41380446e5967c69832bea88351a9331 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 196 | 61 | 4 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 | |
| ToppCell | proximal-Endothelial-Capillary-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.53e-04 | 197 | 61 | 4 | ddb8ea895f0f34d4f20a0740b708fa0f3e378801 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-04 | 197 | 61 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.53e-04 | 197 | 61 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | proximal-Endothelial-Capillary|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.53e-04 | 197 | 61 | 4 | 53baef54bd85c60ae24a3c163b3a3d937fb6ff0b | |
| ToppCell | proximal-3-Endothelial-Capillary|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.53e-04 | 197 | 61 | 4 | a1a61c03d67272693ec23e0d15f0a12bf618e2da | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.53e-04 | 197 | 61 | 4 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-04 | 198 | 61 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-04 | 198 | 61 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.59e-04 | 199 | 61 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.62e-04 | 200 | 61 | 4 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 1.62e-04 | 200 | 61 | 4 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 200 | 61 | 4 | 8954553c05849f3cd591ec663d9caeff2035e168 | |
| Disease | Bilateral renal hypoplasia | 3.93e-06 | 2 | 59 | 2 | C0431692 | |
| Disease | FEV/FEC ratio | JCAD HIVEP2 KLHL7 GPR157 MRC2 PRXL2A PAX2 MTCL1 HERC1 TRMT61B MN1 | 2.76e-05 | 1228 | 59 | 11 | EFO_0004713 |
| Disease | heart rate response to exercise | 8.85e-05 | 43 | 59 | 3 | EFO_0009184 | |
| Disease | Intellectual Disability | 2.67e-04 | 447 | 59 | 6 | C3714756 | |
| Disease | Feeding difficulties | 5.89e-04 | 18 | 59 | 2 | C0232466 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 8.05e-04 | 21 | 59 | 2 | C1292769 | |
| Disease | autism spectrum disorder symptom | 9.68e-04 | 23 | 59 | 2 | EFO_0005426 | |
| Disease | bone density | 1.07e-03 | 388 | 59 | 5 | EFO_0003923 | |
| Disease | maximal oxygen uptake measurement | 1.24e-03 | 26 | 59 | 2 | EFO_0004887 | |
| Disease | energy expenditure | 1.34e-03 | 27 | 59 | 2 | EFO_0005109 | |
| Disease | Drug habituation | 1.60e-03 | 115 | 59 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 1.60e-03 | 115 | 59 | 3 | C0236969 | |
| Disease | Drug abuse | 1.60e-03 | 115 | 59 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 1.60e-03 | 115 | 59 | 3 | C0013222 | |
| Disease | Drug Dependence | 1.60e-03 | 115 | 59 | 3 | C1510472 | |
| Disease | Substance Dependence | 1.60e-03 | 115 | 59 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 1.60e-03 | 115 | 59 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.60e-03 | 115 | 59 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.60e-03 | 115 | 59 | 3 | C4316881 | |
| Disease | Substance abuse problem | 1.64e-03 | 116 | 59 | 3 | C0740858 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.99e-03 | 447 | 59 | 5 | EFO_0000694, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGHQIGLRGSLGVDG | 246 | Q9H0X4 | |
| GGDQGIQTGLLYLAG | 186 | A8MXV6 | |
| PGEQGLQGLTGHKGF | 761 | Q14031 | |
| LGGRTANQIIFGHNG | 671 | Q86XM0 | |
| DGHTVGGLQYGGLGQ | 216 | Q08345 | |
| GGLQYGGLGQLADGV | 221 | Q08345 | |
| FHLDIFGQSLQGGQG | 271 | P16066 | |
| GGNHGLFGALEAVNG | 411 | P54802 | |
| IRSGHGGLNQLGGAF | 6 | Q06710 | |
| LGELGVQGGHQADGP | 1076 | Q9Y4B5 | |
| GHGGVNQLGGVFVNG | 16 | Q02548 | |
| GLSQHLQDGAGGTEG | 21 | P40424 | |
| LNHSLFGVLTGGGGQ | 556 | Q96DN6 | |
| AGGHIAVGQQGLGSV | 301 | Q71F56 | |
| GTRAGQGLQNGHEDG | 36 | Q9P266 | |
| ENGQILTHGSGGKGY | 2046 | Q15751 | |
| LGHNSRGFGVAIVGN | 471 | Q96PD5 | |
| AQAQLEGGLLGLGGH | 306 | Q50LG9 | |
| IFSHGLQGCLEAQGG | 46 | Q9UBG0 | |
| GQGERHVLIFDLGGG | 191 | P34931 | |
| HLGLETGNGGGVINL | 41 | Q96GK7 | |
| DKIFAVGGQNGLGGL | 481 | Q8IXQ5 | |
| GLAGLLGEGVFNFGE | 201 | Q9UNM6 | |
| QGILQGLHLGLGRGC | 571 | Q6ZSS7 | |
| GHGGVNQLGGVFVNG | 16 | Q02962 | |
| GLRFEGQHNQLGGNL | 966 | O94913 | |
| LISVGGQHQGVFGLP | 136 | P50897 | |
| VHGQSLAGAGGGGFL | 1016 | Q8N0W3 | |
| TGTNIGEALGHGLGD | 31 | Q6E0U4 | |
| HLGLETGNGGGVINL | 41 | Q6P2I3 | |
| EGIQNRGHGGGFLTS | 6 | Q96MT8 | |
| VVLHGIGNTFQGGAN | 261 | Q5UAW9 | |
| LFPLSQEELGGGGHQ | 26 | Q9NYQ7 | |
| EGLLGAGGGRNLVAH | 16 | Q92826 | |
| SILGGAHFGEGNGQI | 526 | Q86VB7 | |
| FLQQQHVLGAGGGPG | 181 | Q2VPK5 | |
| GVSHLIQSGGLGGLQ | 776 | Q9H2X9 | |
| VQEIGSGQFGLVHLG | 366 | Q08881 | |
| AQLGHPGDVGQGGLV | 576 | Q10571 | |
| LGGLEGLGQQVGSHF | 11 | Q9NP95 | |
| IGNFGNLIDGGSHHG | 506 | Q2WGJ9 | |
| GQLLSEEGHGAGQEG | 2581 | Q8NF91 | |
| ILYEHQLGQASGLGG | 2521 | Q9Y520 | |
| KSGGGGDIHQGFQSL | 61 | P35237 | |
| NGLGQLGFHVNFEGI | 956 | Q9P2F8 | |
| GDGGNGGHVILRVDQ | 106 | Q9H4K7 | |
| GALQAGLGGYVGDHQ | 146 | Q3SY56 | |
| SGNLEGEGFILGGVF | 171 | Q9BRX8 | |
| GGEGGLQSLLGNMSH | 151 | Q16186 | |
| DGGGVGVGFAQLHNL | 6 | Q5GH73 | |
| QGLGTNSFLHGLGQE | 16 | Q9BVS5 | |
| AGGGSGDLIFQDGHL | 31 | Q8N9B8 | |
| FNGLGLGAVIGLGVA | 696 | O15394 | |
| AGQGHVGNIFQRLSG | 326 | Q9ULX5 | |
| LINDGSGLGFGIVGG | 251 | Q8NI35 | |
| ESHRGSLLLGGGAGQ | 531 | Q9Y5Y9 | |
| GDNVLRIQHGSGFGI | 51 | O75663 | |
| VGGLPGNVSQHLDFG | 116 | Q6ZNG0 | |
| TFGVLLNLGLHAGGG | 226 | Q96G79 | |
| GIGFNIAQVLGQHAG | 1386 | P31629 | |
| GRGLEGLIFSGHQSG | 431 | Q6ZQQ6 | |
| GGVGLNLTGGNHLFL | 1071 | Q9UNY4 |